HXL — Hexima Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Australia Stock Exchange release from HEXIMA : Appendix 3X
Australia Stock Exchange release from HEXIMA : Appointment of Jake Nunn as Non-Executive Director
Australia Stock Exchange release from HEXIMA : Annual Report 2021
Australia Stock Exchange release from HEXIMA : PRE_NR Ends: 15:16:15
Australia Stock Exchange release from HEXIMA : Appendix 4E
Australia Stock Exchange release from HEXIMA : Appendix 4G
Australia's Hexima hits record high on China patent for fungal infection treatment
Australia Stock Exchange release from HEXIMA : PRE_NR Ends: 09:29:39
Australia Stock Exchange release from HEXIMA : China Patent for Pezadeftide Granted
Australia Stock Exchange release from HEXIMA : Design Patent for Pezadeftide Commercial Packaging
Australia Stock Exchange release from HEXIMA : Presenting Clinical Data at APMA and Investor Webinar
Australia's Hexima rises on potential European patent for its onychomycosis treatment
Brief: Hexima Says European Patent Covering Use Of Pezadeftide Will Be Granted On July 14
Australia Stock Exchange release from HEXIMA : Grant of European Patent over Pezadeftide
Australia Stock Exchange release from HEXIMA : Media Interview and Investor Presentation
Australia Stock Exchange release from HEXIMA : ShareCafe Presentation
Australia Stock Exchange release from HEXIMA : Hexima receives INN designation for HXP124
Australia Stock Exchange release from HEXIMA : Grant of HXP124 Patent
Australia Stock Exchange release from HEXIMA : PRE_NR Ends: 09:35:00